Senior insider sale
CMO & EVP Dev & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. — senior position signals high conviction
$2.10M
6.40K shares
What this filing means
GARG PUSHKAL plans to sell 6.40K shares of ALNYLAM PHARMACEUTICALS, INC. valued at approximately $2.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001969223-26-000273
Officer· CMO & EVP Dev & Med Affairs
Since Dec 2021
6.40K
Shares to sell
$2.10M
Approx. market value
1.77K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
RSU
N/A
3/1/2026
805.00RSU
N/A
2/27/2026
970.00Total acquired1.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | RSU N/A | 805.00 | — |
2/27/2026 | RSU N/A | 970.00 | — |
| Total | 1.77K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.63K
Market value
$1.53M
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.77K
Market value
$570.4K
3/3/2026
Total
Units
6.40K
Value
$2.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/27/2026 | 4.63K | $1.53M | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 1.77K | $570.4K | NASDAQ | Planned |
| Total | 6.40K | $2.10M | ||